Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia

Critical Care Medicine
Emmanuel BoselliBernard Allaouchiche

Abstract

To determine the steady-state serum and alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to critically ill patients with ventilator-associated pneumonia and various degrees of renal failure. Prospective comparative study. An intensive care unit and research ward in a university hospital. Forty patients with microbiologically documented ventilator-associated pneumonia. Patients were randomized to receive piperacillin/tazobactam daily continuous infusions of 12/1.5 g or 16/2 g after a loading dose of 4/0.5 g. The serum and alveolar piperacillin/tazobactam concentrations were determined at steady-state with high performance liquid chromatography. The median (interquartile) serum and alveolar piperacillin concentrations were respectively 25.3 mg/L (23.1-32.6) and 12.7 mg/L (6.7-18.0) for 12/1.5 g/day, and 38.9 mg/L (32.9-59.6) and 19.1 mg/L (14.0-21.5), respectively, for 16/2 g/day in patients with no/mild renal failure. In patients with moderate/advance renal failure, the median (interquartile) serum and alveolar piperacillin concentrations were 102.4 mg/L (97.4-112.6) and 44.1 mg/L (33.4-48.3), respectively, for 12/1.5 g/day, and 135.3 mg/L (119.5-146.2) and 54.9 mg/L (45.2-110.3), respective...Continue Reading

References

Dec 1, 1992·Antimicrobial Agents and Chemotherapy·W A Craig, S C Ebert
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·F JehlE Bergogne-Berezin
Dec 22, 1993·JAMA : the Journal of the American Medical Association·J R Le GallF Saulnier
Apr 1, 1993·Anaesthesia·D J Bihari, R W Chang
Apr 1, 1995·Pulmonary Pharmacology·E Bergogne-Berezin
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E Sanders, C C Sanders
Jun 28, 1996·Journal of Chromatography. B, Biomedical Applications·V AugeyF Bressolle
Dec 5, 1998·Clinical Pharmacokinetics·A P MacGowan, K E Bowker
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·P A DargavilleP N McDougall
Sep 4, 2001·Annales Françaises D'anesthèsie Et De Rèanimation·E Boselli, B Allaouchiche
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Silke C MuellerBernd Drewelow
Apr 30, 2002·International Journal of Antimicrobial Agents·Ping LiuHartmut Derendorf
Aug 9, 2003·American Journal of Respiratory and Critical Care Medicine·Koichi YamazakiMasaharu Nishimura
Dec 5, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Naomi R FloreaDavid P Nicolau
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Mario CazzolaSerafino A Marsico
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Loretta M Chiu, Guy W Amsden
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Markus MuellerHartmut Derendorf
Dec 29, 2004·International Journal of Antimicrobial Agents·Christine BuckWilhem Dieter Paar
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Jun 22, 2005·The Journal of Antimicrobial Chemotherapy·Dominique L MonnetNiels Frimodt-Møller
Jul 4, 2006·International Journal of Antimicrobial Agents·Mohammad Reza RafatiMohammad Reza Fazeli
Apr 27, 2007·The Journal of Antimicrobial Chemotherapy·J M Andrews, UNKNOWN BSAC Working Party on Susceptibility Testing

❮ Previous
Next ❯

Citations

Dec 20, 2008·Current Infectious Disease Reports·Guillaume Dufour, Philippe Montravers
Jul 10, 2012·The Journal of Antimicrobial Chemotherapy·Gurudatt ChandorkarObiamiwe Umeh
May 2, 2008·Critical Care Medicine·Jason A RobertsJeffrey Lipman
Feb 9, 2011·Antimicrobial Agents and Chemotherapy·T P LodiseG L Drusano
Nov 15, 2011·Antimicrobial Agents and Chemotherapy·Martin G KeesG L Drusano
Aug 18, 2012·Annals of Intensive Care·Mohd H Abdul-AzizJason A Roberts
Sep 15, 2011·Critical Care : the Official Journal of the Critical Care Forum·Joao Gonçalves-Pereira, Pedro Póvoa
Jun 13, 2009·Critical Care : the Official Journal of the Critical Care Forum·Federico Pea, Pierluigi Viale
Oct 5, 2010·Drugs·Jean-Louis VincentSilvia Cianferoni
Jan 28, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Seth R BauerWilliam H Fissell
Mar 25, 2014·International Journal of Antimicrobial Agents·Jocelyn TeoAndrea Lay-Hoon Kwa
Jul 20, 2010·Expert Opinion on Drug Metabolism & Toxicology·Yoshiro HayashiJeffrey Lipman
Dec 26, 2012·Advances in Chronic Kidney Disease·William H Fissell
Dec 23, 2015·Annals of Intensive Care·Patrick M HonoreHerbert D Spapen
Aug 12, 2009·Infectious Disease Clinics of North America·Matthew R MorrellMarin H Kollef
Dec 14, 2011·International Journal of Antimicrobial Agents·Wieslawa DuszynskaAndrzej Kübler
Apr 29, 2014·The Lancet Infectious Diseases·Jason A RobertsUNKNOWN International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the Europe
Sep 15, 2016·Medizinische Klinik, Intensivmedizin und Notfallmedizin·A BrinkmannO R Frey
Jan 21, 2014·The Journal of Antimicrobial Chemotherapy·Gloria WongJason A Roberts
Dec 29, 2016·Current Opinion in Infectious Diseases·Mohd H Abdul-AzizJason A Roberts
Feb 1, 2013·Therapeutic Advances in Infectious Disease·João Gonçalves-PereiraPedro Póvoa
Feb 1, 2018·The Journal of Antimicrobial Chemotherapy·T W FeltonK A Rodvold
Oct 10, 2018·Current Opinion in Infectious Diseases·Aaron J HeffernanJason A Roberts
Sep 13, 2008·Current Opinion in Critical Care·Marc Leone, Claude Martin
Jun 14, 2014·Clinical Pharmacology and Therapeutics·T W FeltonW W Hope
Nov 23, 2019·Expert Review of Anti-infective Therapy·Filippo AnnoniFabio Silvio Taccone
Jun 10, 2009·Current Opinion in Infectious Diseases·Emilio Bouza, Almudena Burillo
Mar 24, 2018·Drugs·A J HeffernanJ A Roberts
May 7, 2020·Critical Care : the Official Journal of the Critical Care Forum·Frédéric FrippiatNathalie Layios
Jan 28, 2018·Expert Opinion on Drug Metabolism & Toxicology·Marco FalconeManjunath Pai
Sep 25, 2018·Critical Care : the Official Journal of the Critical Care Forum·Rui Pedro Veiga, José-Artur Paiva
Nov 4, 2020·Antimicrobial Agents and Chemotherapy·Marco M CustodioRenee-Claude Mercier
Apr 3, 2021·SAGE Open Medicine·Brandon K HawkinsJamie L Wagner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Fanak FahimiSeyed Mohammad Reza Hashemian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Thomas P LodiseGeorge L Drusano
International Journal of Antimicrobial Agents
Christine BuckWilhem Dieter Paar
© 2022 Meta ULC. All rights reserved